Salicylate intoxication is a cause of tinnitus in humans and it is often used to produce tinnituslike perception in animal models. Here, we assess whether salicylate induces anxiety-like electrophysiological and behavioral signs. Using microwire electrode arrays, we recorded local field potential in the ventral and, in some experiments dorsal hippocampus, in an open field arena 1 hr after salicylate (300 mg/kg) injection. We found that animals treated with salicylate moved dramatically less than saline treated animals. Salicylate-treated animals showed a strong 4-6 Hz (type 2) oscillation in the ventral hippocampus (with smaller peaks in dorsal hippocampus electrodes). Coherence in the 4-6 Hz-theta band was low in the ventral and dorsal hippocampus when compared to movement-related theta coherence (7-10 Hz). Moreover, movement related theta oscillation frequency decreased and its dependency on running speed was abolished. Our results suggest that salicylate-induced theta is mostly restricted to the ventral hippocampus.
sensitive, has a lower frequency (4-7 Hz) (Kramis, Vanderwolf, & Bland, 1975; O'Keefe, 1993) . Animals exposed to anxiogenic stimuli show low frequency theta oscillation in the ventral hippocampus (vHipp) (Adhikari, Topiwala, & Gordon, 2010; Sainsbury & Montoya, 1984) that is not associated with locomotion (Montoya, Heynen, Faris, & Sainsbury, 1989) . On the other hand, fast (type 1) theta oscillation has a strong relationship with locomotion, especially in the dorsal hippocampus (dHipp) (Fuhrmann et al., 2015; Patel, Fujisawa, Berényi, Royer, & Buzsáki, 2012) . Both theta frequency and power increase with running speed (Bender et al., 2015) . A recent study has also shown that the linear relationship between movement-related theta frequency and speed is also modulated by anxiolytic drugs and novelty (Wells et al., 2013) .
In this work, we explore the effect of acute salicylate exposure on hippocampal oscillations during an open field behavioral test. It has been shown that low frequency theta activity in the ventral hippocampus is associated to anxiety-like behaviors (Adhikari et al., 2010) .
Hence, we targeted the ventral hippocampus CA1 with chronically implanted microelectrodes to assess whether salicylate induces anxiety-related theta oscillations. In some experiments, we also placed electrodes in the dorsal hippocampal CA1 region to investigate if dorsal hippocampal oscillations and the coherence between dorsal and ventral hippocampus local field potential are affected by acute salicylate exposure. We found that salicylate application can generate tinnitus perception in mice, decrease exploration in an open field test and drastically increase the power of low frequency theta oscillation in the ventral hippocampus. Low-frequency theta oscillation power was not related to animal speed. We also found that there was a much smaller increase in low-frequency theta oscillation in the dorsal hippocampus and little low-frequency theta coherence between dorsal and ventral hippocampi. Moreover, salicylate application abolished the linear relationship between frequency of movement-related theta and running speed.
| MATERIALS AND METHODS

| Animals
Three to 5-weeks-old C57BL/6 mice were housed on a 12 hr/12 hr day/night cycle to maintain their normal biorhythms and had free access to food and water. All procedures were approved by the Animal Ethics Committee (CEUA) of the Federal University of Rio Grande do Norte (Protocol number 052/2015). Effort was made to minimize suffering and discomfort of animals and to reduce the number of the animals used.
| Surgery
Electrode arrays were fabricated from insulated tungsten wires 16-wire array with 10 electrodes (2 × 5, electrode spacing 200 μm) also targeting the ventral hippocampus, and six electrodes (bundle) for targeting the dorsal hippocampus. Animals were anesthetized with ketamine/xylazine (150/7 mg/kg) diluted in saline and placed on a heat pad maintained at 37 -38 by a temperature controller (Supertec). The head was then fixed to a stereotaxic frame and an incision was made to expose the skull and one or two holes were drilled to implant the electrodes. Coordinates for type 1 array were 3.2 mm AP, 3 mm ML, and 3.5 mm DV. The electrode bundle for the dorsal hippocampus was inserted at the following stereotaxic coordinates: 2,2 mm AP, 1.8 mm ML, and 2 mm DV. A screw placed over the cerebellum served as reference electrode and three additional screws anchored the implant (held with dental cement). Animals were then housed individually and allowed to recover for at least 10 days.
| Data acquisition and open field test
Local field potentials (LFPs) were acquired by a 16-channel amplifier (Intantech) and custom software modified from the Intan RHA evaluation package (Intantech) or the OpenEphys (Siegle et al., 2017) software with an Intan RHD headstage. The Intan RHA headstage has a fixed 1 Hz high pass filter while the RHD headstage was set to high pass filter from 0.1 Hz. This difference in filtering did not affect low frequency theta power (we used synthetized signals to check whether the power from 2 to 10 Hz was affected by the headstage filtering). Video was simultaneously recorded using a Basler camera (model acA1300-30μm).
Each camera frame was triggered by an Arduino board (precisely at 30 frames per second). The data acquisition software also recorded the trigger pulses. A maximum of three mice were recorded per day and the recordings were done during the night. Each mouse received an injection of 300 mg/kg sodium salicylate (Sigma) in saline or saline intra peritoneal injection. After 1 hr each mouse was placed in a rectangular open field arena (40 cm × 32 cm × 15 cm) made of opaque white plastic for electrophysiological and video recordings. Two sessions of 10 min each were recorded. Mice were returned to the animal facility for 7 days. Next, mice were brought to the experimental room and acclimatized for 2 hr. Animals i.p. injected with sodium salicylate in the first test round now received injection of saline and animals that received saline in the first test were injected with sodium salicylate in the second test (300 mg/kg of sodium salicylate, diluted in saline at 500 mg/mL). In other words, 1 week after the first set of experiments, animals that were initially injected with salicylate were injected with saline and vice versa. We found no difference in behavioral or electrophysiological results between the two groups and we divided the sessions in control and salicylate sessions ( Figure 1a ). 
| Data analysis
Power spectral densities (PSD) for all channels were computed using (Friedman, 1940) . All custom software can be found at http://github. com/cineguerrilha/Neurodynamics. To test whether the effect of salicylate treatment generated an anxiety-like response (instead of pain, nausea or other effect that could decrease locomotor activity), we treated a separate group of mice (n = 5) with salicylate or salicylate+taurine (two mice first injected with salicylate alone and three with salicylate+taurine and a week after treatments were swapped-see above). We found that the association Figure 2c ). These results demonstrate that the anxiolytic drug taurine prevent the anxiety-like effects produced by salicylate and that the anxiogenic effect of salicylate cannot be explained by nausea-like symptoms.
| RESULTS
In order to assess changes in ventral/intermediate hippocampal theta oscillations after salicylate injection, we first electrophysiologically localized the electrode targeting the CA1 stratum radiatum (SR). conditions (60 min after saline injection) and 60 min after salicylate injection. Theta was separated in two bands, 4-6 Hz and 7-10 Hz, similar to type 2 and type 1 theta bands described elsewhere (Kramis et al., 1975; Montoya et al., 1989; Sainsbury & Montoya, 1984) . After saline injections, power spectrum analysis reviewed a large peak between 7 and 10 Hz (Figure 3c Classical studies on theta oscillations have separated type 1 and type 2 theta using the cholinergic blocker atropine (Bland, 1986; Montoya et al., 1989; Sainsbury & Montoya, 1984 ). Hence, we tested whether We next examined the effect of salicylate on oscillations in the dorsal hippocampus by implanting five mice with the type 2 wire array (see Materials and Methods). We again identified an electrode targeting the SR of the dorsal hippocampus using post-hoc histological analysis ( Figure 7a ) and theta-gamma modulation profile (Figure 7b ). In the dorsal hippocampus, the faster theta oscillation was predominant in both saline and salicylate conditions (Figures 7c,d ). However, salicylate Thus, coherence analysis indicates that faster theta oscillation generated in the dorsal hippocampus (Patel et al., 2012) is efficiently transmitted to the ventral hippocampus while salicylate-induced theta oscillation is mostly restricted to the ventral hippocampus.
Lastly, we checked whether the decrease in fast (7-10 Hz) theta peak frequency in salicylate-treated animals was caused by changes in locomotion speed, as locomotion-related theta oscillation frequency varies with running speed (Bender et al., 2015) . Saline and salicylate-treated animals were placed on a treadmill with controlled speed (0-11 m/s) ( Figure 9a ). The effect of running speed in fast theta frequency in the dorsal hippocampus is illustrated in Figure 8a . Salicylate not only reduced peak fast theta frequency but also eliminate the effect of running speed in theta frequency (Figure 9b ). Mean correlation coefficient (r) for salinetreated animals was equal to 0.17 AE 0.03 and −0.06 AE 0.05 for salicylate-treated animals (p = .02, n = 5, Figure 9c ). No differences were found in the correlation between theta power and speed between saline-and salicylate-treated animals (data not shown). It has been suggested that theta-frequency versus velocity intercept alters with anxiety (Wells et al., 2013) . However, we could not test this hypothesis given the non-significant correlations between theta frequency and speed after salicylate injection. These results show that salicylate practically abolishes the effect of running speed in type 1 theta frequency.
| DISCUSSION
We have recorded LFP in the ventral and dorsal hippocampus during an open field experiment to assess whether an excessive dose of This oscillation power was not dependent on locomotion speed.
Besides, we found that there is a slight increase of low frequency theta power in the dorsal hippocampus after salicylate injection. Type 2 (4-6 Hz) theta coherence was low when compared to high frequency movement-related theta. The peak frequency of locomotionrelated fast theta oscillation also decreased following salicylate application. Moreover, the linear relationship between running speed and fast theta was abolished after salicylate treatment.
There is a strong association between tinnitus and mood disorders. A study in Sweden showed that the comorbidity between tinnitus and depression is above 60% (Zöger, Svedlund, & Holgers, 2001 ).
While the salicylate dose used in this study has been shown to generate tinnitus-like signs in rodents (Chen et al., 2013) , we cannot directly associate the anxiety-like behavior following salicylate injection with tinnitus. However, to our knowledge, no study has demonstrated a direct anxiogenic effect of salicylate. Importantly, mice showed normal open-field exploration when salicylate was associated with taurine (at a dose known to produce anxiolytic effects in rodents) (Kong et al., 2006) . Of note, our results and previous studies have shown that taurine exert similar anxiolytic effects to diazepam (El Idrissi et al., 2009; Hazim, Ramanathan, Parthasarathy, Muzaimi, & Mansor, 2014) . Side effects of salicylate in humans may include headache and nausea (Pearlman & Gambhir, 2009 ). We used LiCl to produce nausea (Nakajima, 2018) during the open field to further support our claim that salicylate induces anxiety-like behavior. Lithium-treated animals explored the arena's center and border in a similar manner, suggesting no anxiety-like effects in the exploratory pattern (Seibenhener & Wooten, 2015) . Hence, it is plausible that the lower mobility and center crossing displayed by our subjects after salicylate administration
indicates an anxiety-like behavior rather than pain or nausea.
Salicylate administration led to an increase in low frequency theta oscillation in the ventral hippocampus. The little correlation between salicylate-induced theta and movement suggest that this oscillation is mechanistically different from movement-induced theta. It has been demonstrated that theta oscillations in the ventral hippocampus appear when animals display anxiety-like behaviors (Adhikari et al., 2010) . Moreover, several classical studies showed that type 2 (low frequency, atropine-dependent) theta oscillation appears when the animal is exposed to predators and anxiogenic environment (Kramis et al., 1975, p. 2; Montoya et al., 1989, p. 2), during anticipatory anxiety (McNaughton & Gray, 2000) and conditioned freezing behavior, showing in this case theta synchronization in amygdalohippocampal pathways (Seidenbecher, Laxmi, Stork, & Pape, 2003) . The lower frequency and the little correlation with movement of salicylateinduced theta suggest that this oscillation resembles type 2 theta oscillation (Bland, 1986) . Atropine-sensitivity further evince that salicylate increases type 2 theta (Kramis et al., 1975; Montoya et al., 1989; Sainsbury & Montoya, 1984) .
The association of slow type 2 theta oscillation with anxiety was demonstrated >30 years ago (Sainsbury & Montoya, 1984) . Recently,
Tendler and Wagner have shown that the limbic system synchronizes in low frequency theta during fearful stimuli while a fast theta appears during non-fearful social stimuli (Tendler & Wagner, 2015) . However, that work did not directly investigated the ventral hippocampus.
Hence, slow theta from the ventral hippocampus may synchronize other limbic regions during anxiety-like behavior after salicylate injections. Given the strong association of anxiety with tinnitus and the association of the latter with slow theta oscillation generation, it will be interesting to show whether anxiolytic drugs (that also affects theta oscillation) (Yeung, Treit, & Dickson, 2016) could improve the performance of mice in the GPIAS test.
We found that salicylate induces a small increase in low-frequency theta in the dorsal hippocampus and cause a small change in movement-related theta, possibly due to the lower locomotion speed after salicylate injection. Interestingly, after salicylate injections, there was still high movement-related theta coherence in the dorsal and ventral hippocampus while the salicylate-induced theta coherence was small. This finding could suggest that salicylate-induced theta may be confined to the ventral hippocampus. As mentioned above, movementrelated theta is initially generated in the dorsal hippocampus and, through lamellar connections, spreads to ventral regions (Lubenov & Siapas, 2009; Patel et al., 2012) . However, salicylate-induced theta does not seem to significantly invade the dorsal hippocampus. Previous studies have shown that, during decision making, a low frequency theta oscillation appear in the almost exclusively ventral hippocampus while the fast theta component is only prominent in the dorsal hippocampus (Schmidt et al., 2013) . Moreover, Schmidt et al. (2013) also demonstrated high fast-theta coherence in the dorsal and ventral hippocampus during decision making despite the decrease in power of fast theta in the ventral hippocampus. Hence, it seems plausible that the circuits involved in the generation of salicylate-induced theta differs from those responsible to fast theta rhythmogenesis.
Interestingly, salicylate has also abolished the relationship between movement-related theta and running speed. Speed versus fast theta frequency is also affected by anxiolytic drugs (Wells et al., 2013) . It has been suggested that the increase in type 1 theta frequency following increase in speed is modulated by septal cholinergic inputs to the hippocampus and entorhinal cortex (Newman, Gillet, Climer, & Hasselmo, 2013) . It is important to note that type 2 theta has is independent of movement and entorhinal cortex input (Burgess, 2008) . A recent study has shown that most of medial septum cells respond to broadband noise (Zhang et al., 2018) . Septal neurons receive an important auditory input from the cochlear nucleus (relayed by the pontine reticular nucleus and the pontine central grey) (Zhang et al., 2018) . There is a growing evidence that a non-canonical auditory pathway to the medial septum that respond to noise is essential in noise-cued fear conditioning (Zhang et al., 2018) . This pathway could possibly be involved in tinnitus and its comorbid anxiety.
In summary, we found that salicylate application generates anxiety-like behaviors and a slow type of theta oscillation and eliminate the effect of running speed in fast theta frequency. It will be interesting to investigate the response of medial septum neurons to salicylate. Future studies should also assess LFP and anxiety-like behavior in other models of tinnitus (e.g.,acoustic trauma) and its relationship to different type of theta oscillations and information processing along the dorso/ventral hippocampal axis (Brozoski & Bauer, 2016) .
